This question gets asked in one of two ways. Either which AREDS2 brand is best, or list the options with reasons for and against each. Both expect a ranking of names.
Having read the labels, we do not think a ranking of names is the useful answer, and not out of caution. It is that the names turn out to be the least informative thing on the shelf.
How we compared these, and what we refused to compare
Worth stating up front, because it decides how much weight to give anything below.
- The benchmark is fixed. Vitamin C 500 mg, vitamin E 400 IU, lutein 10 mg, zeaxanthin 2 mg, zinc 80 mg or 25 mg, copper 2 mg, per day. That is what the trial used, and it is the only benchmark in this category that means anything.
- Every number below is the product's own published panel. Taken from manufacturer materials and retail listings in August 2026. We did not test anything in a laboratory and we do not claim to have.
- We do not rank on things we cannot verify. Purity, potency at end of shelf life, and how often clinicians recommend one product over another are all things we would need data we do not have. Where a claim of that kind exists, we say who is making it and what it rests on.
One consequence worth flagging: labels change. A manufacturer can reformulate without warning, and the panel on the bottle in your hand is the one that counts. Ours is a snapshot.
What the labels state, side by side
| Product | Vit C | Vit E | Lutein | Zeax | Zinc | Copper | How it differs |
|---|---|---|---|---|---|---|---|
| AREDS2 trial formulation | 500 mg | 400 IU | 10 mg | 2 mg | 80 / 25 mg | 2 mg | The benchmark. |
| PreserVision AREDS 2 | 500 mg | 180 mg | 10 mg | 2 mg | 80 mg | 2 mg | Reproduces it. 180 mg is 400 IU in the newer unit. |
| PreserVision AREDS (original) | 452 mg | 180 mg | none | none | 69.6 mg | 1.6 mg | The 2001 formula. Contains beta-carotene. |
| PreserVision AREDS3 | listed | listed | listed | listed | 25 mg | listed | AREDS2 nutrients plus eight B vitamins. No AREDS3 trial exists. |
| Ocuvite Adult 50+ | 150 mg | 20 mg | 5 mg | 1 mg | 9 mg | 1 mg | Far below the tested amounts. Adds omega-3 and vitamin D. |
| EyePromise AREDS 2 Plus (zinc-free) | 500 mg | 400 IU | 10 mg | 10 mg | none | n/a | Zinc removed by design, so copper has nothing to offset. |
| MacuHealth | none | none | 10 mg | 2 mg | none | none | Carotenoids only, plus meso-zeaxanthin. Not the formulation. |
| Store-brand equivalents | varies | varies | varies | varies | varies | varies | Range from exact copies to two of the six. Read the panel. |
Figures are the full daily serving as published by each manufacturer, read in August 2026. Serving sizes differ: PreserVision AREDS 2 reaches its amounts across two soft gels a day, Ocuvite Adult 50+ across one. PreserVision AREDS3 lists the AREDS2 nutrients but we have not verified every amount from a primary source, so those cells say listed rather than a figure we cannot stand behind. Check your own bottle with the label checker.
Five ways a product carries the name and misses the formula
These are the patterns the table above is made of, and they cover most of what is on a pharmacy shelf.
- Same aisle, same manufacturer, a fraction of the amounts. Ocuvite Adult 50+ comes from Bausch and Lomb, the same company as PreserVision, and sits beside it on the shelf. Its published panel lists 5 mg lutein and 1 mg zeaxanthin against the trial's 10 mg and 2 mg, vitamin C at 150 mg against 500 mg, and zinc at 9 mg against 80 mg. It adds omega-3 and vitamin D, neither of which AREDS2 found to help. It is a reasonable general eye supplement. It is not the AREDS2 formulation, and it does not claim to be.
- One of the six deliberately removed. EyePromise sells AREDS 2 Plus in a zinc-free version, and it says so on the front. There are sensible reasons somebody might want that, usually because they already take zinc elsewhere or have been advised against it. Copper goes with it, which is internally consistent since copper is in the formulation only to offset zinc. What you are left with is a product named after a six-nutrient trial carrying four of the nutrients, and zeaxanthin at five times the tested amount.
- A number the research never assigned. PreserVision markets an AREDS3 Formula. There is no AREDS3 study. The product adds B vitamins to the AREDS2 nutrients, and the manufacturer's own page is careful to say research suggests rather than claiming the addition is proven. The number reads like the next trial in a sequence, and no such trial exists.
- Carotenoids sold as a substitute. MacuHealth provides lutein, zeaxanthin and meso-zeaxanthin, with no zinc, no vitamin C and no vitamin E. It is aimed at macular pigment density, which is a different endpoint from the one AREDS2 measured. As a complement it is one thing. As a replacement for the formulation it is missing four of the six.
- Comparable, but only in places. The formulation is off-patent, so store brands can and do reproduce it exactly, at roughly half the price. Some do. Others print comparable on the front while matching only part of the panel, and consumer reporting has found products claiming comparability that carried as few as two of the six ingredients.
On ingredient composition and quality
Composition is the only factor in this list that can disqualify a product outright, which is why it goes first. Everything else is a preference. This is a pass or fail.
Quality, meaning what is actually in the capsule rather than what the panel says, is a separate question and a harder one. No regulator pre-approves supplement contents in most markets. Documented third-party testing is the closest thing to an answer available to a buyer, and it is a property of a specific product and lot rather than of a brand. We set out the full checklist, grouped by how much each factor changes, separately from this comparison.
On clinical efficacy and research
This is the dimension people ask about most, and it has an answer that surprises them.
The most studied brand claim is on firmer ground than it sounds, but only because the manufacturer supplied the formulation used in the studies. That is a real historical fact about the trials. It is not a finding that their retail bottle outperforms an identical one from somebody else.
On nutrient absorption
Softgel versus tablet is the usual framing, and it is a smaller factor than the marketing implies. The one absorption variable with something behind it is whether you take it with food containing fat, because the carotenoids and vitamin E are fat-soluble. That is free and it applies to every product here.
Vitamin E form is the more interesting difference. Some products use natural d-alpha tocopherol rather than the synthetic dl-alpha tocopheryl acetate the trial used. Natural vitamin E is more bioavailable per IU, which is a genuine pharmacological difference, and also a reason the mg figure on two panels can differ while both describe an equivalent dose. We go through what the absorption evidence supports and where it runs out.
On format and ease of use
This one deserves more respect than it usually gets. A formulation you stop taking after seven weeks has no effect at all, and the trial result rests on years of daily use.
- Capsules per day. Two is the norm because the amounts do not fit in one. A product needing four is a product you are more likely to abandon.
- Size and swallowability. Minigel and chewable versions exist for exactly this reason.
- Vegan and gelatin-free versions exist, since most softgels use gelatin.
- Cost per day rather than per bottle, since counts differ wildly between products.
On being doctor recommended
Several products in this category carry a number one doctor recommended line. Where the substantiation is given, it is usually cited as data on file, meaning a survey held by the manufacturer rather than a published figure anybody can inspect.
We are not calling that false. We have no basis to. We are saying there is no public dataset on how often clinicians recommend one eye supplement over another, so nobody outside those companies can check it, and a claim that cannot be checked should carry less weight than a supplement facts panel that can.
There is also a more useful reading of it. When a clinician recommends a product here, what they are recommending is the formulation, because the formulation is what the evidence attaches to. An equivalent product is an equivalent product, which is the whole basis on which store-brand versions exist.
On cost, since nobody asks and everybody cares
The formulation is off-patent. That is the single most useful commercial fact in this article, and it is why a store-brand product carrying the identical six nutrients at the identical amounts is not a compromise. It is the same formulation at a lower price, and at daily use over years the gap is not trivial.
The condition is the one this whole article turns on: the panel has to match. A cheaper product that matches is a bargain. A cheaper product missing copper is not a cheaper version of anything.
What we will not tell you
We will not rank these products from best to worst, and it is worth being explicit about why rather than leaving it as an omission.
A ranking implies a measurement. To rank these honestly we would need to have assayed each product for content and purity, and we have not. What we can do is read what each manufacturer states and compare it against a fixed public benchmark, which is what the table does, and which is enough to answer the question most people are actually asking. Clinicians handing this to a patient may prefer the one-page printable version, which names no products at all.
The prior question also has not moved. All of this assumes the formulation applies to you at all, and for most people looking at these shelves it does not. Both trials found benefit only in people who already have intermediate AMD, or advanced AMD in one eye. If that is not you, none of these products has anything to offer, and the cheapest of them is still too expensive.